Artificial intelligence-powered medical technologies are rapidly evolving into applicable solutions for clinical practice. Deep learning algorithms can deal with increasing amounts of data provided by wearables, smartphones, and other mobile monitoring sensors in different areas of medicine. Currently, only very specific settings in clinical practice benefit from the application of artificial intelligence, such as the detection of atrial fibrillation, epilepsy seizures, and hypoglycemia, or the diagnosis of disease based on histopathological examination or medical imaging. The implementation of augmented medicine is long-awaited by patients because it allows for a greater autonomy and a more personalized treatment, however, it is met with resistance from physicians which were not prepared for such an evolution of clinical practice. This phenomenon also creates the need to validate these modern tools with traditional clinical trials, debate the educational upgrade of the medical curriculum in light of digital medicine as well as ethical consideration of the ongoing connected monitoring. The aim of this paper is to discuss recent scientific literature and provide a perspective on the benefits, future opportunities and risks of established artificial intelligence applications in clinical practice on physicians, healthcare institutions, medical education, and bioethics.

The aim of this work is to perform a network analysis on the French adaptation of the interpersonal reactivity index (IRI) scale from a large Belgian database and provide additional information for the construct of empathy. We analyze a database of 1973 healthy young adults who were queried on the IRI scale. A regularized partial correlation network is estimated. In the visualization of the model, items are displayed as nodes, edges represent regularized partial correlations between the nodes. Centrality denotes a node's connectedness with other nodes in the network. The spinglass algorithm and the walktrap algorithm are used to identify communities of items, and state-of-the-art stability analyses are carried out. The spinglass algorithm identifies four communities, the walktrap algorithm five communities. Positive edges are found among nodes belonging to the same community as well as among nodes belonging to different communities. Item 14 ("Other people's misfortunes do not usually disturb me a great deal") shows the highest strength centrality score. The network edges and node centrality order are accurately estimated. Network analysis highlights interesting connections between indicators of empathy; how these results impact empathy models must be assessed in further studies.

Bayesian Networks are probabilistic graphical models that represent conditional independence relationships among variables as a directed acyclic graph (DAG), where edges can be interpreted as causal effects connecting one causal symptom to an effect symptom. These models can help overcome one of the key limitations of partial correlation networks whose edges are undirected. This tutorial aims to introduce Bayesian Networks to identify admissible causal relationships in cross-sectional data, as well as how to estimate these models in R through three algorithm families with an empirical example data set of depressive symptoms. In addition, we discuss common problems and questions related to Bayesian networks. We recommend Bayesian networks be investigated to gain causal insight in psychological data.

Artificial intelligence-powered medical technologies are rapidly evolving into applicable solutions for clinical practice. Deep learning algorithms can deal with increasing amounts of data provided by wearables, smartphones and other mobile monitoring sensors in different areas of medicine.Currently, only very specific settings in clinical practice benefit from the application of artificial intelligence, such as the detection of atrial fibrillation, epilepsy seizures, and hypoglycemia, or the diagnosis of disease based on histopathological examination or medical imaging. The implementation of augmented medicine is long-awaited by patients because it allows for a greater autonomy and a more personalized treatment, however, it is met with resistance from physicians which were not prepared for such an evolution of clinical practice.This phenomenon also creates the need to validate these modern tools with traditional clinical trials, debate the educational upgrade of the medical curriculum in light of digital medicine as well as ethical consideration of the ongoing connected monitoring. The aim of this paper is to discuss recent scientific literature and provide a perspective on the benefits, future opportunities and risks of established artificial intelligence applications in clinical practice on physicians, healthcare institutions, medical education and bioethics.

The brain undergoes ionizing radiation (IR) exposure in many clinical situations, particularly during radiotherapy for malignant brain tumors. Cranial radiation therapy is related with the hazard of long-term neurocognitive decline. The detrimental ionizing radiation effects on the brain closely correlate with age at treatment, and younger age associates with harsher deficiencies. Radiation has been shown to induce damage in several cell populations of the mouse brain. Indeed, brain exposure causes a dysfunction of the neurogenic niche due to alterations in the neuronal and supporting cell progenitor signaling environment, particularly in the hippocampus—a region of the brain critical to memory and cognition. Consequent deficiencies in rates of generation of new neurons, neural differentiation and apoptotic cell death, lead to neuronal deterioration and lasting repercussions on neurocognitive functions. Besides neural stem cells, mature neural cells and glial cells are recognized IR targets. We will review the current knowledge about radiation-induced damage in stem cells of the brain and discuss potential treatment interventions and therapy methods to prevent and mitigate radiation related cognitive decline.